DUBLIN–(BUSINESS WIRE)–The “Bipolar Depression – Epidemiology Forecast to 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.
This ‘Bipolar Depression – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Bipolar Depression epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Epidemiology Perspective
The Bipolar Depression epidemiology division provides insights about the historical and current Bipolar Depression patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
In the year 2020, the total diagnosed prevalent case of bipolar depression was 3,552,076 cases in the 7MM which are expected to grow during the study period, i.e., 2017-2030.
The disease epidemiology covered in the report provides historical as well as forecasted Bipolar Depression epidemiology [segmented as Total Diagnosed Prevalent Cases of Bipolar Depression, Type-specific Diagnosed Prevalent Cases of Bipolar Depression, Severity-specific Diagnosed Prevalent Cases of Bipolar Depression, and Total Treated Cases of Bipolar Depression] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2030.
Country Wise- Bipolar Depression Epidemiology
In the United States, the total number of diagnosed prevalent cases of bipolar depression was 2,401,287 cases in the year 2020 which are expected to grow during the study period, i.e., 2017-2030.
In the year 2020, the total diagnosed prevalent cases of bipolar depression were 1,004,168 cases in EU-5 which are expected to grow during the study period, i.e., 2017-2030.
In Japan, the total number of diagnosed prevalent cases of bipolar depression was 146,621 cases in the year 2020 which are expected to grow during the study period, i.e., 2017-2030.
Scope of the Report
The Bipolar Depression report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
The Bipolar Depression Report and Model provide an overview of the risk factors and global trends of Bipolar Depression in the seven major markets (7MM: The United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan).
The report provides insight about the historical and forecasted patient pool of Bipolar Depression in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
The report assesses the disease risk and burden and highlights the unmet needs of Bipolar Depression.
The report provides the segmentation of the Bipolar Depression epidemiology by total diagnosed prevalent cases in the 7MM.
The report provides the segmentation of the Bipolar Depression epidemiology by type-specific diagnosed prevalent cases in the 7MM.
The report provides the segmentation of the Bipolar Depression epidemiology by severity-specific diagnosed prevalent cases in the 7MM.
The report provides the segmentation of the Bipolar Depression epidemiology by total treated cases in the 7MM.
Key Questions Answered
What will be the growth opportunities in the 7MM concerning the patient population of Bipolar Depression?
What are the key findings of the Bipolar Depression epidemiology across the 7MM and which country will have the highest number of patients during the study period (2017-2030)?
What would be the total number of patients of Bipolar Depression across the 7MM during the study period (2017-2030)?
Among the EU5 countries, which country will have the highest number of patients during the study period (2017-2030)?
At what CAGR the patient population is expected to grow in the 7MM during the study period (2017-2030)?
What are the various recent and upcoming events which are expected to improve the diagnosis of Bipolar Depression?
Study Period: 2017-2030
In the 7MM, the total type-specific diagnosed prevalent cases of Bipolar Depression were 1,535,495 for Bipolar I Disorder and 2,016,580 for Bipolar II Disorder in the year 2020.
In the 7MM, the total severity-specific diagnosed prevalent cases of Bipolar Depression were 137,465, 761,210, and 2,653,401 cases for mild, moderate, and severe, respectively in the year 2020.
In the 7MM, the total treated cases of Bipolar Depression was 1,887,186 cases in the year 2020, which will probably rise during the study period, i.e., 2017-2030.
Key Topics Covered:
1. Key Insights
2. Report Introduction
3. Executive Summary of Bipolar Depression
4. Epidemiology Methodology
5. Disease Background and Overview
5.1. Introduction
5.2. Difference between Bipolar and Unipolar Depression
5.3. Classification of BD According to DSM-5
5.4. Signs and symptoms
5.5. Causes
5.6. Risk Factors
5.7. Pathophysiology
5.8. Genetic Findings in BD
5.9. Biomarkers
6. Diagnosis of Bipolar Disorder
6.1. Diagnostic criteria for major forms of BD
6.1.1. Diagnosis to rule out thyroid disorders
6.2. Differential Diagnosis
6.3. Diagnostic Guidelines
6.3.1. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology Guidelines
6.3.2. The National Institute for Health and Care Excellence (NICE) guidelines for the diagnosis of the bipolar disorder
7. Epidemiology and Patient Population
7.1. Key Findings
7.2. Epidemiology of Bipolar Depression
7.3. Epidemiology Scenario: 7MM
7.3.1. Total Diagnosed Prevalent Cases of Bipolar Depression
7.3.2. Type-specific Diagnosed Prevalent Cases of Bipolar Depression
7.3.3. Severity-specific Diagnosed Prevalent Cases of Bipolar Depression
7.3.4. Total Treated Cases of Bipolar Depression
8. The United States
8.1. Total Diagnosed Prevalent Cases of Bipolar Depression
8.2. Type-specific Diagnosed Prevalent Cases of Bipolar Depression
8.3. Severity-specific Diagnosed Prevalent Cases of Bipolar Depression
8.4. Total Treated Cases of Bipolar Depression
9. EU-5
9.1. Germany
9.2. France
9.3. Italy
9.4. Spain
9.5. The United Kingdom
10. Japan
10.1. Total Diagnosed Prevalent Cases of Bipolar Depression
10.2. Type-specific Diagnosed Prevalent Cases of Bipolar Depression
10.3. Severity-specific Diagnosed Prevalent Cases of Bipolar Depression
10.4. Total Treated Cases of Bipolar Depression
11. Appendix
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/1nxbqx
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900